Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Morandi

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 30, 2013
Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammationFabio Morandi, Consuelo Venturi, Roberta Rizzo, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsFabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Oncotarget|September 3, 2015
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferationFabio Morandi, Barbara Morandi, Alberto L Horenstein, et al.
Oncoimmunology|October 26, 2018
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastomaFabio Morandi, Loredana Amoroso, Alessandra Dondero, et al.
Biomed Research International|July 11, 2015
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall SurvivalSara Stigliani, Michela Croce, Fabio Morandi, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Pediatric Blood & Cancer|October 14, 2011
Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signaturePaola Scaruffi, Fabio Morandi, Fabio Gallo, et al.
Plos One|January 19, 2012
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteinsFabio Morandi, Paola Scaruffi, Fabio Gallo, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 30, 2013
Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammationFabio Morandi, Consuelo Venturi, Roberta Rizzo, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsFabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Oncotarget|September 3, 2015
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferationFabio Morandi, Barbara Morandi, Alberto L Horenstein, et al.
Oncoimmunology|October 26, 2018
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastomaFabio Morandi, Loredana Amoroso, Alessandra Dondero, et al.
Biomed Research International|July 11, 2015
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall SurvivalSara Stigliani, Michela Croce, Fabio Morandi, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
British Journal of Haematology|February 11, 2021
Molecular dynamics of targeting CD38 in multiple myelomaFabio Malavasi, Angelo C Faini, Fabio Morandi, et al.
Pediatric Blood & Cancer|October 14, 2011
Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signaturePaola Scaruffi, Fabio Morandi, Fabio Gallo, et al.
Plos One|January 19, 2012
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteinsFabio Morandi, Paola Scaruffi, Fabio Gallo, et al.
Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
Pageof 9